News

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...
Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
There are many ways to kill microbes that cause dangerous infections. Combining genetic screening with machine learning can ...
A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...
Researchers have developed a chemical probe to study a key component of the Mycobacterium tuberculosis envelope. Their ...
In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
Placed in a cobalamin-rich culture medium, the bacteria did not grow until the researchers endowed them with the Rv1819c protein from Mycobacterium tuberculosis, which made them proliferate. The team ...
A Florida State University chemistry researcher will use new funding to explore ways to halt tuberculosis, one of the world's ...